Topics

In a small but significant clinical trial, a pill from Mirati Therapeutics developed to block the “undruggable” cancer protein called KRAS showed partial tumor responses. https://buff.ly/34fwvjr 

16:18 EDT 28 Oct 2019 | STAT

In a small but significant clinical trial, a pill from Mirati Therapeutics developed to block the “undruggable” cancer protein called KRAS showed partial tumor responses. https://buff.ly/34fwvjr 

Original Article: In a small but significant clinical trial, a pill from Mirati Therapeutics developed to block the “undruggable” cancer protein called KRAS showed partial tumor responses. https://buff.ly/34fwvjr 

NEXT ARTICLE

More From BioPortfolio on "In a small but significant clinical trial, a pill from Mirati Therapeutics developed to block the “undruggable” cancer protein called KRAS showed partial tumor responses. https://buff.ly/34fwvjr "

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...